Skip to main content
. 2021 Jul 23;46(12):2132–2139. doi: 10.1038/s41386-021-01097-0

Fig. 2. Scatterplots comparing results (p values) from GWAS of TR vs. THR and comparing results of analyses of different patient subsets.

Fig. 2

Scatterplots of -log(p) for (A) analysis of TR vs. analysis of THR in all subjects, (B) analysis of TR vs. analysis of THR in naltrexone-treated subjects, (C) analysis of TR vs. analysis of THR in acamprosate-treated subjects, (D) analysis of TR in acamprosate-treated patients vs. analysis of TR in naltrexone-treated patients, and (E) analysis of THR in acamprosate-treated patients vs. analysis of THR in naltrexone-treated patients.